Antibiotics: Market Analysis & Business Opportunities

The global systemic antibiotics market was valued at $39.6 billion in 2013 and is expected to reach $41.2 billion by 2018, at a CAGR of 0.8%. Since, 2005 this market is seen to grow at an annual rate of 6.6% until 2011. There are many companies manufacturing antibiotic these days and there are many other antibiotics present in the market such as aminoglycoside antibiotics and it covers about 79% of the global demand. Moreover, the other antibiotics such as penicillin have 8%, tetracyclines 4%, erythromycin 7%, streptomycin 1% and chloramnphenicol has 1 % market.

Rising demand for antibiotics to counter increasing cases of drug-resistant infections, combined with decreasing Research and Development (R&D) costs, is presenting an ideal opportunity for pharmaceutical manufacturers to launch novel products into the marketplace, according to a new report from Global Data.

The company’s latest report* states that over the coming years, the growing level of threat posed by multidrug-resistant (MDR) bacteria, particularly gram-negative organisms, will be a key driver behind the growth of the antibiotics market in the US, France, Italy, Germany, Spain and the UK.

A stagnant antibiotic pipeline has escalated medical concerns caused by MDR bacteria in these countries, and a significant unmet need exists for novel antibiotics to counter the problem.

However, low returns on investment (ROIs), primarily caused by expensive R&D processes and convoluted regulatory requirements, have been deterring drug manufacturers from developing new products, according to the report.

The global systemic antibiotics market was valued at $39.6 billion in 2013 and is expected to reach $41.2 billion by 2018, at a CAGR of 0.8%. The global market for antifungal therapeutics was valued at $10.7 billion in 2013 and is projected to reach $12.2 billion in 2018, a five-year compound annual growth rate (CAGR) of 2.7%. Overall sales in the current antibiotics and new products market were nearly $40 billion in 2008. It increased to $41.5 billion in 2009. By 2015, it is projected to increase to $65.5 billion, for a 5-year compound annual growth rate (CAGR) of 9.6%. The largest segment antibiotic drugs market was nearly $36 billion in 2008; this further increased to $37 billion in 2009, this projected to reach $50 billion in 2015, for a 5-year CAGR of 5.9%. Sales in the bacterial vaccines market amounted to $3.6 billion in 2008 which increased slightly to $3.9 billion in 2009. This is projected to increase to $15 billion in 2015, for a 5-year CAGR of 31.6%.

  • Global antibiotics market
  • Antibiotics market Europe
  • Antibiotics market USA
  • Antibiotics market UK

Related Conference of Antibiotics: Market Analysis & Business Opportunities

November 14-15, 2018

13th World Congress on Pharmacology and Toxicology

| Mercure Albert Park | Melbourne, Australia
November 15-16, 2018

9th Global Experts Meeting on Neuropharmacology

Berlin, Germany
January 21-22, 2019 |

14th Annual Meet on Euro Ethnopharmacology

Amsterdam, Netherlands
January 28-29, 2019

12th World Congress on Future Pharma

Paris, France
January 30-31, 2019

19th World Congress on Advances in Pharmaceutical Sciences

Courtyard Marriott Seoul Times Square | Seoul, South Korea
January 31-February 01, 2019

9th World Congress on Chromatography

Paris | France
February 20-21, 2019

World Congress on Drug Discovery and Drug Design

Singapore
February 22-23, 2019 |

13th World Drug Delivery Summit

San Francisco, USA
Feb 28-March 01, 2019

International Conference on Bio-Pharmaceuticals

Osaka, Japan
March 25-26, 2019

World Congress on Pharmaceutical Biotechnology & Bioengineering

Orlando, Florida, USA
March 27-28, 2019

5th International Conference on Clinical Pharmacy and
Health Care

San Antonio, Texas, USA
April 04-06, 2019

4th Annual Congress on Nanomedicine and Drug Delivery

Auckland, NewZealand
April 15-16, 2019

12th European Biosimilars Congress

Berlin, Germany
April 17-18, 2019

11th World Congress on Pharmacology & Therapeutics

Montreal, Canada
April 17-18, 2019

Annual Neurochemistry and Neuropharmacology Congress

| Montreal, Canada
April 17-18, 2019

International Conference on Global Analytica

Osaka, Japan

April 22-23, 2019

6th World Congress on Drug Discovery & Toxicology

Abu Dhabi, UAE
April 22-24, 2019

20th Asia-Pacific Pharma Congress

Tokyo, Japan
April 22-23, 2019

5th Annual Congress on Clinical & Hospital Pharmacy

| Radisson Narita | Tokyo, Japan
May 06-07, 2019

6th World Congress on Advanced Clinical Trials and Clinical Research

| Novotel | Brisbane, Australia
May 06-07, 2019

2nd Annual Pharmaceutical Biotechnology Congress

Radisson Narita | Tokyo, Japan
May 9-11, 2019

11th World Congress on Neuropharmacology

Prague, Czech Republic
May 20-21, 2019

7th World Congress on Antibiotics, Antimicrobials & Antibiotic Resistance

Radisson Hotel Narita | Tokyo, Japan
May 20-22, 2019

21st Annual European Pharma Congress

Zurich, Switzerland
March 22-23, 2019

5th International Conference on Antibiotics

Orlando, USA
June 17-18, 2019

7th European Biopharma Congress

Stockholm, Sweden
June 17-18, 2019

14th World Congress on Pharmacology and Drug Safety

Lisbon, Portugal
June 27-29, 2019

18th Annual Congress on Pharmaceutics & Drug Delivery Systems

Amsterdam, Netherlands
July 19-20, 2019

8th International Conference on Clinical Trials

| Atlanta, USA
July 19-20, 2019

8th International Conference on Clinical Trials

| Atlanta, USA

August 19-20, 2019

24th World Congress on Pharmacology

Vienna, Austria
September 18-19, 2019

6th World Congress on Natural Products, Medicinal Plants and Traditional Medicines

| Radisson Narita | Tokyo, Japan

Antibiotics: Market Analysis & Business Opportunities Conference Speakers

Recommended Sessions

Related Journals

Are you interested in